Stay updated with breaking news from Metropolis health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
However, Sandeep Raina, executive vice president - research, Nuvama Professional Clients Group, believes that much of the concerns are abating and that the stock can be good contra play for long-term investors. ....
KIE not just maintains a cautious call on Dr Lal Pathlabs and Metropolis Healthcare, but also forecasts a strong downside potential in both the counters. ....
After hitting an all-time high in mid-October, benchmark equity indices – Sensex and Nifty – tanked around 9 per cent on the back of a strong selling pressure by Foreign Institutional Investors. ....